A clinical evaluation of chlorphenoxamine with caffeine in the treatment of Parkinson's disease, including a comparison with methixene.
作者信息
Strang R R
出版信息
J Clin Pharmacol J New Drugs. 1967 Jul-Aug;7(4):214-20. doi: 10.1002/j.1552-4604.1967.tb00050.x.
Abstract
摘要
相似文献
1
A clinical evaluation of chlorphenoxamine with caffeine in the treatment of Parkinson's disease, including a comparison with methixene.
J Clin Pharmacol J New Drugs. 1967 Jul-Aug;7(4):214-20. doi: 10.1002/j.1552-4604.1967.tb00050.x.
2
Double-blind clinical evaluation of UCB 1549 in treatment of Parkinson's disease.UCB 1549治疗帕金森病的双盲临床评估。
Br Med J. 1966 Nov 5;2(5522):1112-3. doi: 10.1136/bmj.2.5522.1112.
3
Treatment of Parkinson's disease with chlorphenoxamine.
J Mich State Med Soc. 1960 Sep;59:1364-5.
4
Therapeutic action of methixene hydrochloride on Parkinsonian tremor and a description of a new tremor-recording transducer.盐酸美噻吨对帕金森震颤的治疗作用及一种新型震颤记录换能器的描述。
Br J Pharmacol Chemother. 1966 Feb;26(2):345-50. doi: 10.1111/j.1476-5381.1966.tb01913.x.
5
[Treatment of disturbances of extrapyramidal system with methixene hydrochloride].[盐酸美噻吨治疗锥体外系障碍]
No To Shinkei. 1969 Nov;21(11):1301-9.
6
[Anticholinergic treatment of Parkinson's disease (author's transl)].
Wien Klin Wochenschr. 1976 Oct 15;88(19):641-6.
7
Long-lasting drug holiday in Parkinson's disease.
Adv Neurol. 1987;45:503-6.
8
A double-blind evaluation of S.D. 25 in the treatment of Parkinson's disease.
Curr Med Drugs. 1966 Dec;7(4):20-6.
9
Quantitative measurements of L-dopa therapy in Parkinson's disease.
Neurology. 1970 Apr;20(4):376-7.
10
A comparative study of "UCB 1549" and "SD 25" in the treatment of Parkinson's disease.
Med J Aust. 1967 May 27;1(21):1086-8. doi: 10.5694/j.1326-5377.1967.tb20878.x.
Zotero 插件